The Center for Cholesterol Management - a medical corporation
Lipid Education
Press & Media
About Us
Beating Heart Disease

Lipid Education Home



Heart Disease 

Case Study 

Frequently Asked Questions 

Glossary of Terms 

Resources for Health Care Professionals

Resources for Patients 

Educational Resources
for Health Care Professionals


AATS Guideline for Lung Cancer Screening Using Low Dose Computed Tomography Scans

ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults 2013

ACCF/AHA 2007 Expert Consensus Document on Coronary Artery Calcium Scoring

ACCF/AHA Guidelines for the Management of Heart Failure 2013

ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 Appropriate Use Criteria for Diagnostic Catheterization

ADA/ACC New Guidelines on Lipoprotein Testing

ADA Standards of Medical Care in Diabetes 2008

Advanced Lipoprotein Testing and the Clinical Utility of Inflammatory Markers: Advice from an expert panel of lipid specialists (JCL 2011)

AHA 2014 Heart Disease and Stroke Statistics

AHA/ACC Guidelines for Secondary Prevention 2006

AHA/ACC Guidelines for the Managment of Patients with Valvular Heart Disease:Executive Summary (2014)

AHA Antioxidant Statement 2004

AHA Women CV Prevention Guidelines 2011 Update

AHA Metabolic Syndrome in Children and Adolescents 2009

AHA Statement on Hypertension 2013

AHA Statement on LDL-C vs NonHDL-C vs ApoB as Markers of Cardiovascular Risk 2011

AHA Statement on Omega-3 2002

AHA Statement on Pet Ownership and Cardiovascular Risk

AHA Statement on Triglycerides and CV Disease 2011

AHA Statement on Omega-6 FA 2009

AHA Stroke Prevention 2008

AHA Women CHD Guidelines 2004

AHA Women's Guidelines 2007

AHA/ADA Nonnutritive Sweeteners: Current Use and Health Perspectives

AHA/ASA Oral Antithrombotic Agents for the Prevention of Stroke in Nonvalvular Atrial Fibrillation

AHA/NHLBI Statement on Diagnosis and Management of Metabolic Syndrome

Canadian Dyslipidemia Guidelines 2003

Cardiovascular Risk in Adults in 2013

Current Guidelines for Aspirin Use in Primary/Secondary Prevention

Endocrine Society Hormone Guidelines (2010)

FDA Safety Review of Vytorin/Zetia

NAMS 2010 Position Statement: Estrogen and Progestogen Use In Postmenopausal Women

NCEP 2004 Addendum

NCEP ATP III Cholesterol Guidelines

NCEP ATP III Full and Final Report

NLA Position Statement on the SEAS Trial(Ezetimibe and Cancer)

NLA Recommendations for Patient-Centered Management of Dyslipidemia: Part 1 -- Executive Summary

NLA Recommendations for Patient-Centered Management of Dyslipidemia: Part 1 -- Full Report

Obesity, Adiposity, and Dyslipidemia: A consensus statement from the National Lipid Association

USPSTF Recommendation Statement on the Use of Aspirin